SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-191785
Filing Date
2014-05-09
Accepted
2014-05-09 12:14:16
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d704852d10q.htm 10-Q 281391
2 EX-31.1 d704852dex311.htm EX-31.1 8446
3 EX-31.2 d704852dex312.htm EX-31.2 8473
4 EX-32.1 d704852dex321.htm EX-32.1 2614
5 EX-32.2 d704852dex322.htm EX-32.2 2646
  Complete submission text file 0001193125-14-191785.txt   2781550

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20140331.xml EX-101.INS 276441
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20140331.xsd EX-101.SCH 37358
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20140331_cal.xml EX-101.CAL 47066
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20140331_def.xml EX-101.DEF 207301
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20140331_lab.xml EX-101.LAB 272132
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20140331_pre.xml EX-101.PRE 246721
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 14827794
SIC: 2834 Pharmaceutical Preparations